📣 VC round data is live. Check it out!
- Public Comps
- Cambridge Cognition
Cambridge Cognition Valuation Multiples
Discover Cambridge Cognition's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Co-Diagnostics, Nova Eye Medical, Medclair, Integrum and more.
Cambridge Cognition Overview
About Cambridge Cognition
Cambridge Cognition Holdings PLC is a neuroscience digital health company specializing in the precise measurement of clinical outcomes in neurological disorders. Geographically, it derives majority of its revenue from the United States of America and also has a presence in the United Kingdom, European Union, and Rest of world. The company services include Neuroscience consultancy, Technical consultancy, Study design, Data analysis, Study management, Data management, and Reports and interpretation.
Founded
2012
HQ

Employees
84
Website
Financials (LTM)
EV
$23M
Valuation Multiples
Start free trialCambridge Cognition Financials
Cambridge Cognition reported last 12-month revenue of $14M and negative EBITDA of ($215K).
In the same LTM period, Cambridge Cognition generated $11M in gross profit, ($215K) in EBITDA losses, and had net loss of ($2M).
Revenue (LTM)
Cambridge Cognition P&L
In the most recent fiscal year, Cambridge Cognition reported revenue of $13M and EBITDA of ($674K).
Cambridge Cognition is unprofitable as of last fiscal year, with gross margin of 75%, EBITDA margin of (5%), and net margin of (18%).
Financial data powered by Morningstar, Inc.
Cambridge Cognition Stock Performance
Cambridge Cognition has current market cap of $23M, and enterprise value of $23M.
Market Cap Evolution
Cambridge Cognition's stock price is $0.50.
Cambridge Cognition share price increased by 16.5% in the last year.
Cambridge Cognition has an EPS (earnings per share) of $-0.05.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $23M | $23M | 0.1% | 0.0% | -0.8% | 16.5% | $-0.05 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCambridge Cognition Valuation Multiples
Cambridge Cognition trades at 1.6x EV/Revenue multiple, and (106.4x) EV/EBITDA.
EV / Revenue (LTM)
Cambridge Cognition Financial Valuation Multiples
As of June 3, 2026, Cambridge Cognition has market cap of $23M and EV of $23M.
Cambridge Cognition has a P/E ratio of (14.2x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Cambridge Cognition Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Cambridge Cognition Margins & Growth Rates
Cambridge Cognition grew revenue by 24% but EBITDA decreased by 162% in the last fiscal year.
In the most recent fiscal year, Cambridge Cognition reported gross margin of 75%, EBITDA margin of (5%), and net margin of (18%).
Cambridge Cognition Margins
Cambridge Cognition Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Cambridge Cognition Operational KPIs
Cambridge Cognition's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Cambridge Cognition's Rule of 40 is 26% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Cambridge Cognition's Rule of X is 62% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Cambridge Cognition Competitors
Cambridge Cognition competitors include Co-Diagnostics, Nova Eye Medical, Medclair, Integrum, Genematrix, Finemedix, Biosynex, Lifeward, Elbit Imaging and NextPlat.
Most Cambridge Cognition public comparables operate across Healthcare Software, Medical Devices, B2B SaaS, Vertical SaaS, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 27.0x | 27.0x | (0.6x) | - | |||
| 1.1x | 1.0x | (6.6x) | (14.2x) | |||
| 4.2x | - | 21.4x | - | |||
| 2.0x | - | (5.2x) | - | |||
| 2.0x | - | (18.4x) | - | |||
| 3.2x | - | (20.2x) | - | |||
| 0.8x | - | 60.1x | - | |||
| 0.9x | 0.8x | (1.1x) | - | |||
This data is available for Pro users. Sign up to see all Cambridge Cognition competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Cambridge Cognition
Cambridge Cognition has acquired 2 companies to date.
Last acquisition by Cambridge Cognition was on January 11th 2023. Cambridge Cognition acquired Winterlight Labs for $9M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Cambridge Cognition
| Description | - | Clinpal is a cloud-based eClinical platform developed by eClinicalHealth, an Ireland-headquartered firm supporting clinical trials worldwide. The patient-centric system facilitates real-time data capture from patients, sites, CRAs, and sponsors via mobile apps and web portals. Clinpal consolidates eSource biometrics, ePRO, and eConsent into a unified hub, integrating with EDC systems like Medidata Rave. Deployed in over 100 trials across oncology and rare diseases, the platform boosts retention by 20% through reminders and gamification. |
| HQ Country | ||
| HQ City | - | Stirling |
| Deal Date | 11 Jan 2023 | 12 Oct 2022 |
| Valuation | $9M | $2M |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all Cambridge Cognition acquisitions and their M&A valuation multiples. Start Free Trial | ||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Cambridge Cognition
| When was Cambridge Cognition founded? | Cambridge Cognition was founded in 2012. |
| Where is Cambridge Cognition headquartered? | Cambridge Cognition is headquartered in United Kingdom. |
| How many employees does Cambridge Cognition have? | As of today, Cambridge Cognition has over 84 employees. |
| Is Cambridge Cognition publicly listed? | Yes, Cambridge Cognition is a public company listed on London Stock Exchange. |
| What is the stock symbol of Cambridge Cognition? | Cambridge Cognition trades under COG ticker. |
| When did Cambridge Cognition go public? | Cambridge Cognition went public in 2013. |
| Who are competitors of Cambridge Cognition? | Cambridge Cognition main competitors include Co-Diagnostics, Nova Eye Medical, Medclair, Integrum, Genematrix, Finemedix, Biosynex, Lifeward, Elbit Imaging, NextPlat. |
| What is the current market cap of Cambridge Cognition? | Cambridge Cognition's current market cap is $23M. |
| What is the current revenue of Cambridge Cognition? | Cambridge Cognition's last 12 months revenue is $14M. |
| What is the current revenue growth of Cambridge Cognition? | Cambridge Cognition revenue growth (NTM/LTM) is 23%. |
| What is the current EV/Revenue multiple of Cambridge Cognition? | Current revenue multiple of Cambridge Cognition is 1.6x. |
| Is Cambridge Cognition profitable? | No, Cambridge Cognition is not profitable. |
| What is the current EBITDA of Cambridge Cognition? | Cambridge Cognition has negative EBITDA and is not profitable. |
| What is Cambridge Cognition's EBITDA margin? | Cambridge Cognition's last 12 months EBITDA margin is (2%). |
| What is the current EV/EBITDA multiple of Cambridge Cognition? | Current EBITDA multiple of Cambridge Cognition is (106.4x). |
| What is the current FCF of Cambridge Cognition? | Cambridge Cognition's last 12 months FCF is ($265K). |
| What is Cambridge Cognition's FCF margin? | Cambridge Cognition's last 12 months FCF margin is (2%). |
| What is the current EV/FCF multiple of Cambridge Cognition? | Current FCF multiple of Cambridge Cognition is (86.2x). |
| How many companies Cambridge Cognition has acquired to date? | As of June 2026, Cambridge Cognition has acquired 2 companies. |
| What was the largest acquisition by Cambridge Cognition? | $9M acquisition of Winterlight Labs on 11th January 2023 was the largest M&A Cambridge Cognition has done to date. |
| What companies Cambridge Cognition acquired? | Cambridge Cognition acquired Winterlight Labs and Clinpal. |
| In how many companies Cambridge Cognition has invested to date? | Cambridge Cognition hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Cambridge Cognition
Lists including Cambridge Cognition
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

